Literature DB >> 19542081

A common variant in the adiponutrin gene influences liver enzyme values.

Barbara Kollerits, Stefan Coassin, Stefan Kiechl, Steven C Hunt, Bernhard Paulweber, Johann Willeit, Anita Brandstätter, Claudia Lamina, Ted D Adams, Florian Kronenberg.   

Abstract

BACKGROUND: Two recent genome-wide association studies identified the liver expressed transmembrane protein adiponutrin to be associated with liver related phenotypes such as non-alcoholic fatty liver disease and liver function enzymes. These associations were not uniformly reported for various ethnicities. The aim of this study was to investigate a common non-synonymous variant within adiponutrin (rs738409, exon 3) with parameters of liver function in three independent West Eurasian study populations including a total of 4290 participants.
METHODS: The study was performed in (1) the population based Bruneck Study (n=783), (2) the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk Study from Austria based on a healthy working population (n=1705), and the Utah Obesity Case-Control Study including a group of 1019 severely obese individuals (average body mass index 46.0 kg/m(2)) and 783 controls from the same geographical region of Utah. Liver enzymes measured were alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma-glutamyl transferase (GGT).
RESULTS: A strong recessive association of this polymorphism was found with age and gender adjusted ALT and AST concentrations: being homozygous for the minor allele resulted in a highly significant increase of ALT concentration of 3.53 U/l (p=1.86 x 10(-9)) and of AST concentration of 2.07 U/l (p=9.58 x 10(-6)), respectively. The associations were consistently found in all three study populations.
CONCLUSION: The highly significant associations of this transversion polymorphism within the adiponutrin gene with increased ALT and AST concentrations support a role for adiponutrin as a susceptibility gene for hepatic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542081      PMCID: PMC3759243          DOI: 10.1136/jmg.2009.066597

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  21 in total

1.  SIFT: Predicting amino acid changes that affect protein function.

Authors:  Pauline C Ng; Steven Henikoff
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

2.  Expression, regulation, and triglyceride hydrolase activity of Adiponutrin family members.

Authors:  Andrew C Lake; Ying Sun; Jian-Liang Li; Jae Eun Kim; Jeremy W Johnson; Dongmei Li; Tracy Revett; Heather H Shih; Wei Liu; Janet E Paulsen; Ruth E Gimeno
Journal:  J Lipid Res       Date:  2005-09-08       Impact factor: 5.922

3.  Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgery.

Authors:  Ted D Adams; Erick Avelar; Tom Cloward; Ross D Crosby; Robert J Farney; Richard Gress; R Chad Halverson; Paul N Hopkins; Ronette L Kolotkin; Michael J Lamonte; Sheldon Litwin; Robert T Nuttall; Robert Pendleton; Wayne Rosamond; Steven C Simper; Sherman C Smith; Michael Strong; James M Walker; Gail Wiebke; Frank G Yanowitz; Steven C Hunt
Journal:  Contemp Clin Trials       Date:  2005-10       Impact factor: 2.226

4.  Plasma triglycerides and type III hyperlipidemia are independently associated with premature familial coronary artery disease.

Authors:  Paul N Hopkins; Lily L Wu; Steven C Hunt; Eliot A Brinton
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

5.  Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study.

Authors:  L Bathum; H C Petersen; J U Rosholm; P Hyltoft Petersen; J Vaupel; K Christensen
Journal:  Clin Chem       Date:  2001-01       Impact factor: 8.327

Review 6.  Lipolysis: pathway under construction.

Authors:  Rudolf Zechner; Juliane G Strauss; Guenter Haemmerle; Achim Lass; Robert Zimmermann
Journal:  Curr Opin Lipidol       Date:  2005-06       Impact factor: 4.776

7.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

8.  Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities.

Authors:  Christopher M Jenkins; David J Mancuso; Wei Yan; Harold F Sims; Beverly Gibson; Richard W Gross
Journal:  J Biol Chem       Date:  2004-09-10       Impact factor: 5.157

9.  Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors.

Authors:  John B Whitfield; Gu Zhu; John E Nestler; Andrew C Heath; Nicholas G Martin
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

10.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.

Authors:  Stefano Romeo; Julia Kozlitina; Chao Xing; Alexander Pertsemlidis; David Cox; Len A Pennacchio; Eric Boerwinkle; Jonathan C Cohen; Helen H Hobbs
Journal:  Nat Genet       Date:  2008-09-25       Impact factor: 38.330

View more
  25 in total

Review 1.  Genetic background in nonalcoholic fatty liver disease: A comprehensive review.

Authors:  Fabio Salvatore Macaluso; Marcello Maida; Salvatore Petta
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

2.  Genetic variants in COL13A1, ADIPOQ and SAMM50, in addition to the PNPLA3 gene, confer susceptibility to elevated transaminase levels in an admixed Mexican population.

Authors:  Elena Larrieta-Carrasco; Yvonne N Flores; Luis R Macías-Kauffer; Paula Ramírez-Palacios; Manuel Quiterio; Eric G Ramírez-Salazar; Paola León-Mimila; Berenice Rivera-Paredez; Guillermo Cabrera-Álvarez; Samuel Canizales-Quinteros; Zuo-Feng Zhang; Tania V López-Pérez; Jorge Salmerón; Rafael Velázquez-Cruz
Journal:  Exp Mol Pathol       Date:  2018-01-04       Impact factor: 3.362

3.  A feed-forward loop amplifies nutritional regulation of PNPLA3.

Authors:  Yongcheng Huang; Shaoqing He; John Zhong Li; Young-Kyo Seo; Timothy F Osborne; Jonathan C Cohen; Helen H Hobbs
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-12       Impact factor: 11.205

Review 4.  PNPLA3 I148M variant in nonalcoholic fatty liver disease: demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis.

Authors:  Li-Zhen Chen; Yong-Ning Xin; Ning Geng; Man Jiang; Ding-Ding Zhang; Shi-Ying Xuan
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

5.  The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver disease.

Authors:  Yaron Rotman; Christopher Koh; Joseph M Zmuda; David E Kleiner; T Jake Liang
Journal:  Hepatology       Date:  2010-09       Impact factor: 17.425

Review 6.  PNPLA3 Gene Polymorphism Is Associated With Predisposition to and Severity of Alcoholic Liver Disease.

Authors:  Habeeb Salameh; Evan Raff; Angelika Erwin; Devanshi Seth; Hans Dieter Nischalke; Edmondo Falleti; Maria Antonella Burza; Julian Leathert; Stefano Romeo; Antonio Molinaro; Stefano Ginanni Corradini; Pierluigi Toniutto; Ulrich Spengler; Spengler Ulrich; Ann Daly; Christopher P Day; Yong-Fang Kuo; Ashwani K Singal
Journal:  Am J Gastroenterol       Date:  2015-05-12       Impact factor: 10.864

7.  The genetic architecture of liver enzyme levels: GGT, ALT and AST.

Authors:  Jenny H D A van Beek; Marleen H M de Moor; Eco J C de Geus; Gitta H Lubke; Jacqueline M Vink; Gonneke Willemsen; Dorret I Boomsma
Journal:  Behav Genet       Date:  2013-04-12       Impact factor: 2.805

Review 8.  The genetics of NAFLD.

Authors:  Quentin M Anstee; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-24       Impact factor: 46.802

Review 9.  Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Authors:  Quentin M Anstee; Giovanni Targher; Christopher P Day
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-19       Impact factor: 46.802

10.  The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis.

Authors:  Yasuto Takeuchi; Fusao Ikeda; Yuki Moritou; Hiroaki Hagihara; Tetsuya Yasunaka; Kenji Kuwaki; Yasuhiro Miyake; Hideki Ohnishi; Shinichiro Nakamura; Hidenori Shiraha; Akinobu Takaki; Yoshiaki Iwasaki; Kazuhiro Nouso; Kazuhide Yamamoto
Journal:  J Gastroenterol       Date:  2012-08-07       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.